StructureChemical NameCASMF
ANTI-HUMAN SIRTUIN TYPE 3 (SIRT 3)
ANTI-HUMAN CX3CR1 (V28)
ANTI-HUMAN KAPPA (LIGHT CHAIN), TEXAS RED
ANTI-HUMAN IGG2 FC HRP CONJUGATE
ANTI-HUMAN B203, BIOTIN
ANTI-HUMAN CD206, PE-CY5
ANTHRAX LETHAL FACTOR PROTEASE SUBSTRATE III, FLUOROGENIC C91H156N42O18
ANTI-HIV-1 REV
ANTI-HUMAN GITR EXTRACELLULAR DOMAIN
ANTI-HTLV-II ENVELOPE 801 ANTIGEN
ANTI-HUMAN CX3CL1 CHEMOKINE DOMAIN
ANTI-HUMAN CD135 FITC
ANTI-HUMAN CD11B/MAC-1, ALEXA FLUOR(R) 647
ANTI-HUMAN CD44, APC
ANTI-HUMAN IGF BINDING PROTEIN-5
ANTI-HUMAN IL-16
ANTI-HBSAG (AD/AY)
ANTI-HYGROMYCIN B
ANTHRACENE-9-CARBALDEHYDE (5-PHENYL-1,2,4-TRIAZIN-3-YL)HYDRAZONE C24H17N5
ANTI-HMFG-2, HUMAN
ANTI-HUMAN CD45RO TRI-COLOR(R) (R-PE-CY5 TANDEM)
ANTI-HBRM/HSNF2ALPHA (KR-17)
ANTHRANILYL-HIV PROTEASE SUBSTRATE V 210644-48-7 C50H76N14O13
ANTI-HUMAN STNF RECEPTOR TYPE I, BIOTINYLATED
ANTI-HUMAN TIMP-2 (N-TERMINAL)
ANTI-HPV 16E2 (18-41)
9-ANTHRACENECARBOXAMIDE, POLYMER BOUND
ANTI-HUMAN LAMBDA CHAIN BIOTIN-LC
Anti-Human BAFF(Affinity)
ANTI-HISTONE DEACETYLASE 10 (HDAC10)
ANTI-HUMAN CD53.1, PAN LEUCOCYTES, BLAST-1 FLUORESCEIN (FITC) LABELED
ANTI-HUMAN CD3/CD25
ANTI-HUMAN LUMINAL EPITHELIAL ANTIGEN
ANTI-HUMAN SMC1 PSER966
ANTI-HUMAN CA-MMP, C-TERMINAL
ANTI-HUMAN IGA HEAVY CHAINS FITC CONJUGATE
ANTI-HUMAN/MOUSE EPHRIN B3
ANTI-HUMAN CFTR C-TERMINUS
ANTI-HYPERACETYLATED HISTONE H4 (PENTA)
ANTI-HUMAN ALPHA-F1
ANTI-HOMEOBOX PROSPERO-LIKE PROTEIN PROX1
ANTI-HEPATITIS B SURFACE AG, FLUORESCEIN
Anthranilic Acid-15N 108159-61-1 H2*NC6H4COOH
ANTI-HUMAN IGG (GAMMA) TEXAS RED
ANTI-HUMAN RB (AA 300-380)
ANTI-HUMAN E12
ANTI-HUMAN 2B4, PE
ANTI-HIV-1 P24, HRP
ANTI-HUMAN LYMPHOTOXIN BETAR EXTRACELLULAR DOMAIN
ANTI-HUMAN ALPHA/BETA-SNAP
2-Anthracenesulfonic acid,L-amino-4-[(4-dodecylphenyl)amino]-9,10-dihydro-9,10-dioxo 51957-84-7 C32H38N2O5S
ANTI-HUMAN P-GLYCOPROTEIN (MDR), PE
ANTI-HUMAN (LDL)
ANTI-HUMAN NATURAL KILLER CELL-LIKE
ANTI-HUMAN ARC (NT)
ANTI-HUMAN BASOPHILS
ANTI-HUMAN IGA, IGG AND IGM, TEXAS RED
ANTI-HEPATITIS B SURFACE ANTIGEN
ANTI-HUMAN CD1B
ANTI-HUMAN CD108
ANTI-H1R, RAT, 18AA NEAR NT
ANTI-HUMAN IGG1 ISOTYPE CONTROL FITC
ANTI-HUMAN TNFSF15
ANTI-HUMAN CD152 (CTLA-4)
ANTI-HUMAN IGG - HEAVY CHAIN PHYCOPROBE PC LABELED
ANTI-HIV-2 GAG P26 ANTIGEN
ANTI-HUMAN UBIQUITIN CARBOXYL-TERMINAL HYDROLASE L1
ANTI-HUMAN HIR-B EXON 11
ANTI-HUMAN TFPI KUNITZ DOMAIN 1
ANTI-HUMAN KERATIN 7 (54KDA) AND 17 (46KDA)
ANTI-HUMAN IL-1ALPHA
ANTI-HUMAN CXCR2, PHYCOERYTHRIN
ANTI-HUMAN IGG - HEAVY AND LIGHT CHAINS BIOTIN-CAPROYL LABELED
ANTI-HUMAN IKK-GAMMA
ANTI-HERPES VIRUS 6, P150 POLYPEPTIDE
ANTI-HCV CORE ANTIBODY (FLUORESCEIN CONJUGATE)
ANTI-HUMAN BD-3
ANTI-HUMAN CD40, APC
ANTI-H2AX
ANTI-HUMAN RANK EXTRACELLULAR DOMAIN, BIOTIN
ANTI-HUMAN IGD - HEAVY CHAIN
ANTI-HUMAN CD44 R-PE
ANTI-HUMAN MMP-11
ANTI-HUMAN TRAF3
ANTI-HUMAN CD55, PE-CY5
ANTI-HUMAN B-CELL ANTIGEN FITC CONJUGATED
ANTI-HUMAN TACE/ADAM17 (CT)
ANTI-HUMAN BV23, PE
ANTI-HUMAN CD8, PE-CY5
ANTI-HUMAN P56 LCK, AA 38-52
ANTI-HLA-DP, HUMAN, MHC CLASS II, MONOMORPHIC, AL-CY
ANTI-HUMAN PDGF-AA, BIOTINYLATED
ANTI-HUMAN SIGLEC-9, FITC
ANTI-HUMAN LAMBDA B-GAL
9-(9-Anthroyloxy)stearicacid(9-AS) 69243-44-3
ANTI-HTF, AP
ANTI-HUMAN PRESENILIN, SHARED SEQUENCE
9-ANTHRACENE METHOXYPOLY(ETHOXY) ACRYLATE
ANTHRACENE-D10 SOLUTION 100UG/ML IN METHANOL 5ML C14H9D
9,10-Anthracenedione, 1-amino-, reaction products with copper oxide (CuO) and 3,9-dibromo-7H-benz[de]anthracen-7-one, chlorinated 68608-72-0 C31H17Br2CuNO4
1491 1492 1493 1494 1495 1496 1497 1498 1499 1500 1501 1502 1503 1504 1505 1506 1507 1508 1509 1510 1511 1512 1513 1514 1515 1516 1517 1518 1519 1520 1521 1522 1523 1524 1525 1526 1527 1528 1529 1530 1531 1532 1533 1534 1535 1536 1537 1538 1539 1540 1541 1542 1543 1544 1545 1546 1547 1548 1549 1550 1551 1552 1553 1554 1555 1556 1557 1558 1559 1560 1561 1562 1563 1564 1565 1566 1567 1568 1569 1570 1571 1572 1573 1574 1575 1576 1577 1578 1579 1580 1581 1582 1583 1584 1585 1586 1587 1588 1589 1590 1591 1592 1593 1594 1595 1596 1597 1598 1599 1600 1601 1602 1603 1604 1605 1606 1607 1608 1609 1610 1611 1612 1613 1614 1615 1616 1617 1618 1619 1620 1621 1622 1623 1624 1625 1626 1627 1628 1629 1630 1631 1632 1633 1634 1635 1636 1637 1638 1639 1640 1641 1642 1643 1644 1645 1646 1647 1648 1649 1650 1651